A pilot study of a virtually delivered dissonance-based eating disorder prevention program for young women with type 1 diabetes: within-subject changes over 6-month follow-up.

Journal: Eating disorders

Volume: 

Issue: 

Year of Publication: 

Affiliated Institutions:  Regional Department for Eating Disorders, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. Division of Childhood and Adolescent Medicine, Oslo University Hospital, Oslo, Norway. Department of Psychiatry and Behavioral Science, Stanford University, Stanford, USA. Department of Psychiatry, University of Toronto, Toronto, Canada. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. Oslo Centre of Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway. Oslo Diabetes Research Centre, Oslo, Norway.

Abstract summary 

In an uncontrolled study, we previously demonstrated the feasibility and preliminary efficacy of our virtual diabetes-specific version () of the eating disorder (ED) prevention program the . The aim of the current study was to evaluate further this program for women with type 1 diabetes (T1D) by assessing within-subject changes in outcomes from pretest over 6-month follow-up.Young women with T1D aged 16-35 years were invited to participate in groups. A total of 35 participants were allocated to five groups (six meetings over 6 weeks). Primary outcome measures included ED risk factors and symptoms, and secondary outcomes included three T1D-specific constructs previously found to be associated with ED pathology: glycemic control as measured by HbA1c level, diabetes distress, and illness perceptions.Within-subject reductions, with medium-to-large effect sizes, were observed for the primary (ED pathology, body dissatisfaction, thin-ideal internalization, and appearance ideals and pressures) and secondary outcomes (within-condition Cohen's s ranged from .34 to 1.70).The virtual appears to be a promising intervention worthy of more rigorous evaluation. A randomized controlled trial with at least a 1-year follow-up is warranted to determine its efficacy compared to a control condition.

Authors & Co-authors:  Wisting Haugvik Wennersberg Hage Stice Olmsted Ghaderi Brunborg Skrivarhaug Dahl-Jørgensen

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  11
Identifiers
Doi : 10.1080/10640266.2024.2331391
SSN : 1532-530X
Study Population
Women
Mesh Terms
Other Terms
Study Design
Study Approach
Country of Study
Publication Country
United States